(Q33545612)

27 July 2017

1 reference

title

Reduction in health care resource utilization associated with extended-release theophylline (English)

1 reference

27 July 2017

Schulz RM

1

1 reference

27 July 2017

Yates WN Jr

series ordinal

2

1 reference

27 July 2017

publication date

1 March 1999

1 reference

Annals of Allergy, Asthma & Immunology

27 July 2017

published in

1 reference

27 July 2017

volume

82

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

267-272

1 reference

Evaluation of oral bronchodilator therapy in asthmatic children. Bronchodilators in asthmatic children.

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962607-5

7 January 2021

Relative efficacy of maintenance therapy with theophylline, inhaled albuterol, and the combination for chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962607-5

7 January 2021

Theophylline in the management of asthma: time for reappraisal?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962607-5

7 January 2021

Theophylline: potential antiinflammatory effects in nocturnal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962607-5

7 January 2021

Anti-inflammatory effects of low-dose oral theophylline in atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962607-5

7 January 2021

Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962607-5

7 January 2021

The value of maintenance theophylline in steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962607-5

7 January 2021

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962607-5

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962607-5

7 January 2021

Management of asthma and chronic airflow limitation. Are methylxanthines obsolete?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962607-5

7 January 2021

Aminophylline Therapy for Acute Bronchospastic Disease in the Emergency Room

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962607-5

7 January 2021

Use of Medicaid data for pharmacoepidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962607-5

7 January 2021

Initial experience with partial liquid ventilation in pediatric patients with the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962607-5

7 January 2021

The effect of a pulmonary rehabilitation program on self-efficacy, perception of dyspnea, and physical endurance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962607-5

7 January 2021

Falls among nursing home residents: an examination of incident reports before and after restraint reduction programs

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962607-5

7 January 2021

10.1016/S1081-1206(10)62607-5

Identifiers

DOI

1 reference

release_li2m6gobfjdlnjeeo33vaeghou

27 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/li2m6gobfjdlnjeeo33vaeghou

24 November 2022

mapped directly with Wikidata item

1 reference